• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管局部区域性胰腺癌老年患者的短期发病率和死亡率较高,但切除术仍能带来获益。

Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality.

机构信息

Department of Surgery, University of Texas Medical Branch, Galveston, Texas, USA.

出版信息

J Am Geriatr Soc. 2011 Apr;59(4):647-54. doi: 10.1111/j.1532-5415.2011.03353.x. Epub 2011 Mar 31.

DOI:10.1111/j.1532-5415.2011.03353.x
PMID:21453378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3156667/
Abstract

OBJECTIVES

To evaluate time trends in surgical resection rates and operative mortality in older adults diagnosed with locoregional pancreatic cancer and to determine the effect of age on surgical resection rates and 2-year survival after surgical resection.

DESIGN

Retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) and linked Medicare claims database (1992-2005).

SETTING

Secondary data analysis of population-based tumor registry and linked claims data.

PARTICIPANTS

Medicare beneficiaries aged 66 and older diagnosed with locoregional pancreatic cancer (N=9,553), followed from date of diagnosis to time of death or censorship.

MEASUREMENTS

Percentage of participants undergoing surgical resection, 30-day operative mortality after resection, and 2-year survival according to age group.

RESULTS

Surgical resection rates increased significantly, from 20% in 1992 to 29% in 2005, whereas 30-day operative mortality rates decreased from 9% to 5%. After controlling for multiple factors, participants were less likely to be resected with older age. Resection was associated with lower hazard of death, regardless of age, with hazard ratios of 0.46, 0.51, 0.47, 0.43, and 0.35 for resected participants younger than 70, 70 to 74, 75 to 79, 80 to 84, and 85 and older respectively compared with unresected participants younger than 70 (P<.001).

CONCLUSION

With older age, fewer people with pancreatic cancer undergo surgical resection, even after controlling for comorbidity and other factors. This study demonstrated increased resection rates over time in all age groups, along with lower surgical mortality rates. Despite previous reports of greater morbidity and mortality after pancreatic resection in older adults, the benefit of resection does not diminish with older age in selected people.

摘要

目的

评估老年局部区域性胰腺癌患者手术切除率和手术死亡率的时间趋势,并确定年龄对手术切除率和手术切除后 2 年生存率的影响。

设计

利用监测、流行病学和最终结果(SEER)和相关医疗保险索赔数据库(1992-2005 年)的数据进行回顾性队列研究。

设置

人群肿瘤登记处和相关索赔数据的二次数据分析。

参与者

年龄在 66 岁及以上、被诊断为局部区域性胰腺癌的医疗保险受益人(N=9553),从诊断日期开始随访至死亡或截止日期。

测量

根据年龄组,接受手术切除的参与者比例、切除术后 30 天手术死亡率和 2 年生存率。

结果

手术切除率显著增加,从 1992 年的 20%增加到 2005 年的 29%,而 30 天手术死亡率从 9%下降到 5%。在控制多种因素后,参与者的年龄越大,越不可能接受切除。无论年龄大小,切除与较低的死亡风险相关,与年龄小于 70 岁的未切除参与者相比,年龄小于 70 岁、70-74 岁、75-79 岁、80-84 岁和 85 岁及以上的切除参与者的死亡风险比分别为 0.46、0.51、0.47、0.43 和 0.35(P<.001)。

结论

随着年龄的增长,接受胰腺癌手术切除的患者越来越少,即使在控制了合并症和其他因素后也是如此。本研究显示,所有年龄组的手术切除率随着时间的推移都有所增加,同时手术死亡率也有所下降。尽管之前有报道称老年患者胰腺切除术后发病率和死亡率更高,但在选定人群中,年龄增长不会降低切除的益处。

相似文献

1
Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality.尽管局部区域性胰腺癌老年患者的短期发病率和死亡率较高,但切除术仍能带来获益。
J Am Geriatr Soc. 2011 Apr;59(4):647-54. doi: 10.1111/j.1532-5415.2011.03353.x. Epub 2011 Mar 31.
2
Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands.老年患者的胰腺癌手术:短期伤害与长期益处之间的平衡。荷兰的一项基于人群的研究。
Acta Oncol. 2016;55(3):278-85. doi: 10.3109/0284186X.2015.1105381. Epub 2015 Nov 9.
3
What is the effect of age on pancreatic resection?年龄对胰腺切除术有何影响?
Adv Surg. 2009;43:233-49. doi: 10.1016/j.yasu.2009.02.004.
4
Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.老年早期胰腺癌患者手术切除治疗的应用不足。
Surgery. 2015 Nov;158(5):1226-34. doi: 10.1016/j.surg.2015.04.031. Epub 2015 Jun 29.
5
A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.老年胰腺腺癌患者行胰腺切除术与化疗的生存结局比较分析。
Cancer. 2016 Nov 15;122(21):3378-3385. doi: 10.1002/cncr.30199. Epub 2016 Jul 15.
6
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.胰腺癌根治性切除术后的预后因素:一项基于人群的396例患者的关联数据库分析。
Ann Surg. 2003 Jan;237(1):74-85. doi: 10.1097/00000658-200301000-00011.
7
672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.672例胰腺腺泡细胞癌患者:基于人群的与胰腺腺癌的比较。
Surgery. 2008 Aug;144(2):141-8. doi: 10.1016/j.surg.2008.03.006. Epub 2008 May 27.
8
En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?胰腺癌局部进展期的整块切除:是否值得?
J Gastrointest Surg. 2002 Mar-Apr;6(2):147-57; discussion 157-8. doi: 10.1016/s1091-255x(01)00063-4.
9
Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.胰腺切除术:减少胰腺腺癌种族差异的关键组成部分。
Cancer. 2009 Sep 1;115(17):3979-90. doi: 10.1002/cncr.24433.
10
Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma.长期使用劳拉西泮可能与胰腺腺癌患者更差的长期预后相关。
Surgery. 2025 Mar;179:108794. doi: 10.1016/j.surg.2024.08.027. Epub 2024 Sep 20.

引用本文的文献

1
Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors.揭示21世纪胰腺癌的负担:发病率、死亡率、生存率及主要影响因素的趋势
Cancers (Basel). 2025 May 9;17(10):1607. doi: 10.3390/cancers17101607.
2
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.老年胰腺腺癌患者管理的最新进展:肿瘤内科角度。
Clin Transl Oncol. 2024 Jul;26(7):1570-1583. doi: 10.1007/s12094-024-03386-8. Epub 2024 Feb 8.
3
Pancreatic surgery in elderly patients: results of 329 consecutive patients during 10 years.

本文引用的文献

1
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.胰腺癌切除术后氟尿嘧啶加亚叶酸辅助化疗与吉西他滨的随机对照试验。
JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275.
2
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
3
The effect of age on short-term outcomes after pancreatic resection: a population-based study.年龄对胰腺切除术后短期结局的影响:一项基于人群的研究。
老年患者的胰腺手术:10年间329例连续患者的手术结果
Front Med (Lausanne). 2023 May 26;10:1166402. doi: 10.3389/fmed.2023.1166402. eCollection 2023.
4
Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis.年龄对接受手术的胰腺癌患者的预后影响:一项倾向评分匹配分析
Front Oncol. 2022 Mar 31;12:789351. doi: 10.3389/fonc.2022.789351. eCollection 2022.
5
Achieving 'Marginal Gains' to Optimise Outcomes in Resectable Pancreatic Cancer.实现“微小进步”以优化可切除胰腺癌的治疗效果
Cancers (Basel). 2021 Apr 1;13(7):1669. doi: 10.3390/cancers13071669.
6
Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database.胰腺和壶腹周围肿瘤的非切除性手术探查:来自国家数据库的报告。
Scand J Surg. 2021 Sep;110(3):344-350. doi: 10.1177/1457496920913669. Epub 2020 Apr 17.
7
Hepatobiliary and pancreatic surgery in the elderly: Current status.老年肝胆胰外科:现状
Ann Hepatobiliary Pancreat Surg. 2020 Feb;24(1):1-5. doi: 10.14701/ahbps.2020.24.1.1. Epub 2020 Feb 27.
8
Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer.老年可切除胰腺癌患者的手术治疗与非手术治疗比较:一项回顾性研究可切除胰腺癌的治疗结果。
BMC Cancer. 2019 Nov 12;19(1):1090. doi: 10.1186/s12885-019-6255-3.
9
An update on treatment options for pancreatic adenocarcinoma.胰腺腺癌治疗方案的最新进展。
Ther Adv Med Oncol. 2019 Sep 25;11:1758835919875568. doi: 10.1177/1758835919875568. eCollection 2019.
10
Pancreatic resections in elderly patients with high American Society of Anesthesiologists' risk score: a view from a tertiary care center.高龄患者行胰腺切除术:来自三级医疗中心的观点。(注:American Society of Anesthesiologists' risk score,缩写为 ASA 评分,是一种用于评估手术患者全身麻醉风险的量表。)
Aging Clin Exp Res. 2020 May;32(5):935-950. doi: 10.1007/s40520-019-01276-6. Epub 2019 Jul 25.
Ann Surg. 2008 Sep;248(3):459-67. doi: 10.1097/SLA.0b013e318185e1b3.
4
Outcomes in octogenarians undergoing high-risk cancer operation: a national study.八旬老人接受高风险癌症手术的结果:一项全国性研究。
J Am Coll Surg. 2007 Dec;205(6):729-34. doi: 10.1016/j.jamcollsurg.2007.06.307. Epub 2007 Oct 1.
5
Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team building.在一所学术机构启动胰十二指肠切除术关键路径——多学科团队建设的第一步。
J Am Coll Surg. 2007 May;204(5):917-23; discussion 923-4. doi: 10.1016/j.jamcollsurg.2007.01.057.
6
Hospital readmission after pancreaticoduodenectomy.胰十二指肠切除术后的医院再入院情况。
J Gastrointest Surg. 2006 Nov;10(9):1243-52; discussion 1252-3. doi: 10.1016/j.gassur.2006.08.016.
7
Pancreatic cancer in the general population: Improvements in survival over the last decade.普通人群中的胰腺癌:过去十年生存率的改善。
J Gastrointest Surg. 2006 Nov;10(9):1212-23; discussion 1223-4. doi: 10.1016/j.gassur.2006.08.010.
8
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.1423例胰腺癌胰十二指肠切除术:单中心经验
J Gastrointest Surg. 2006 Nov;10(9):1199-210; discussion 1210-1. doi: 10.1016/j.gassur.2006.08.018.
9
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.切除的壶腹周围腺癌:5年生存者及其6至10年随访
Surgery. 2006 Nov;140(5):764-72. doi: 10.1016/j.surg.2006.04.006. Epub 2006 Aug 28.
10
In search of the perfect comorbidity measure for use with administrative claims data: does it exist?寻找适用于行政索赔数据的完美共病测量方法:它存在吗?
Med Care. 2006 Aug;44(8):745-53. doi: 10.1097/01.mlr.0000223475.70440.07.